Clinical Trial Update: First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

This report covers a first-in-man Phase 1 trial of the investigational compound NNC0142-0002 in patients with rheumatoid arthritis. The study status is listed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• NNC0142-0002

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Inflammation, Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2013-10-21